IKZF1 and acute lymphoblastic leukemia: Like those with Ph+ ALL, most patients with Ph-like ALL (70%) have hallmark IKZF1 alterations [66,69,71,72], which are associated with high rates of induction therapy failure and a high risk of relapse [57,73].